InspireMD, Inc. (NASDAQ:NSPR) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Representatives Marvin Slosman - Chief Executive Officer Craig Shore - Chief Financial Officer David Holmes - LifeSci Advisors Conference Call Participants Ben Haynor - Alliance Global Partners Operator Greetings! Welcome to InspireMD, Third Quarter 2021 Earnings Call. At this time all participants are in a listen-only mode. [Operator Instructions]. Please note, this conference is being recorded. I will now t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35731 InspireMD, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Emplo ...

Start Time: 8:30 January 1, 0000 8:51 AM ET InspireMD, Inc. (NASDAQ:NSPR) Q2 2021 Earnings Conference Call August 10, 2021, 08:30 AM ET Company Participants Marvin Slosman - CEO Craig Shore - CFO Jules Abraham - CORE IR Conference Call Participants Benjamin Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to the InspireMD Second Quarter 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a list ...

Sustained Embolic Protection Disclaimers This presentation contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forwardlooking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35731 InspireMD, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer i ...

InspireMD, Inc. (NASDAQ:NSPR) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Scott Gordon - President, Core IR, IR Marvin Slosman - CEO Craig Shore - CFO Conference Call Participants Benjamin Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to the InspireMD First Quarter 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35731 InspireMD, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Emplo ...

InspireMD, Inc. (NASDAQ:NSPR) Q4 2020 Earnings Conference Call March 9, 2021 8:30 AM ET Company Participants Scott Gordon - President, Core IR, Investor Relations Marvin Slosman - Chief Executive Officer Craig Shore - Chief Financial Officer Conference Call Participants Benjamin Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to the InspireMD Year End 2020 Financial Results and Corporate Update Conference Call. At this time, all participan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-K (Mark One) [X]ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-35731 InspireMD, Inc. (Exact name of registrant as specified in its charter) Delaware 26-2123838 (State or other jurisdiction of incorporation or organization) 4 Men ...

InspireMD, Inc. (NASDAQ:NSPR) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Scott Gordon - President, Core IR, Investor Relations Marvin Slosman - Chief Executive Officer Craig Shore - Chief Financial Officer Conference Call Participants Benjamin Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to InspireMD Third Quarter 2020 Financial Results and Corporate Update Conference Call. At this time, all partic ...